Accessibility Menu
Optigenex logo

Optigenex(OTC) OPGX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Optigenex last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-17
Optigenex stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-03
1 month+0%USD 0.002026-06-26
3 month+0%USD 0.002026-05-07
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-08-08
3 year-99.97%USD 1.002023-07-24
5 year-99.94%USD 0.512021-08-18
Since inception-100%USD 637,525.502005-04-15

Optigenex Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$634.51K

Net Income (TTM)

-$3.91M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

301.80 (High)

Price

$0.00

Volume

9

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

N/A

OPGX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Optigenex

Optigenex Inc. is a company focused on producing and distributing products that promote healthy aging and enhance beauty. The company’s flagship offering, AC-11, is a potent extract derived from rainforest plants, designed to assist in DNA repair and slow skin aging.

Products and Services
  • AC-11, a bioactive ingredient for skincare and dietary supplements
  • Products for anti-aging topical skincare and cosmetics
  • Distribution to manufacturers and retailers globally
Growth Outlook
  • AC-11 is gaining traction in the anti-aging market
  • Increasing demand for natural ingredients in cosmetics
  • Expansion into new markets is underway
Financial Highlights
  • Recent quarterly revenue of 182,820 reflects growth potential
  • Net income of 1,014,600 indicates operational profitability
  • Current ratio of 0.10 suggests liquidity challenges
Optigenex Inc. operates in the Medical - Diagnostics & Research industry, with a focus on innovative solutions for beauty and health. The company is headquartered in Melissa, Texas, and serves a diverse global market. The recent quarterly financials show a revenue of 182,820, which highlights the company's ability to generate income despite challenges. The net income of 1,014,600 indicates a positive operational performance, suggesting that the company is on a path toward profitability. However, the current ratio of 0.10 points to potential liquidity issues that may need addressing. Overall, Optigenex Inc. presents an intriguing opportunity for investors interested in the health and beauty sector, particularly in natural and effective solutions for aging.
AI Generated • Aug 29, 2026

Industry

Chemicals

Sector

Materials

Headquarters

Melissa, TX 75454, US

OPGX Financials

Key Financial Metrics (TTM)

Gross Margin

-22.10%

Operating Margin

298.48%

Net Income Margin

-621.88%

Return on Equity

46.25%

Return on Capital

110.52%

Return on Assets

-153.46%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

400

Volume

9

Avg. Volume

1.703

Financials (TTM)

Gross Profit

-$16.48K

Operating Income

$1.13M

EBITDA

$1.84M

Operating Cash Flow

-$176.38K

Capital Expenditure

$0.00

Free Cash Flow

-$176.38K

Cash & ST Invst.

$21.40K

Total Debt

$11.43M

Optigenex Performance Analysis

Optigenex sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-3063.4%
Q42007-12-31-29.8%
Q12008-03-3184.8%
Q22008-06-30-6.4%
Optigenex sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32007-09-30N/A
Q42007-12-31-100.0%
Q12008-03-31N/A
Q22008-06-30100.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2008YOY CHG

Revenue

$182.82K

+98.4%

Gross Profit

$119.04K

+81.7%

Gross Margin

65.11%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$1.01M

+237.1%

EBITDA

-$196.42K

+36.8%

Quarterly Fundamentals

Name
Q2 2008YOY CHG

Total Cash

$21.40K

-50.0%

Total Debt

$11.43M

+62.9%

Accounts Receivable

$0.00

-100.0%

Inventory

$368.93K

-56.9%

Long Term Debt

$3.24M

-53.7%

Short Term Debt

$8.18M

N/A

Return on Assets

-1.53%

N/A

Return on Invested Capital

-44.42%

N/A

Free Cash Flow

-$137.94K

-15.6%

Operating Cash Flow

-$137.94K

-15.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MHTXManhattan Scientifics, Inc.
$0.00+0.00%
BIOIFBiome Grow Inc.
$0.00+0.00%
CBGLCannabis Global Inc.
$0.00-50.00%
SPPHSpencer Pharmaceutical Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About OPGX

What is the current price of Optigenex?

Optigenex is trading at $0.00 per share.

What is the 52-week range for Optigenex?

Over the past 52 weeks, Optigenex has traded between $0.00 and $0.04.

How much debt does Optigenex have?

Optigenex total debt is unavailable.

How much cash does Optigenex have on hand?

Optigenex does not have cash on hand data available.

What is Optigenex’s dividend yield?

Optigenex does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.